Form4insider filings, from the source

SEC Form 4 · accession 0000899243-17-008731

CytomX Therapeutics, Inc. · CTMX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Mark J Levin
10% Owner
Kevin P Starr
10% Owner
TRV GP, LLC
10% Owner
Period of report
Mar 23, 2017
Accepted (ET)
Mar 27, 2017 · 7:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501989

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 23, 2017S1,000,000$17.0002D5,820,348D
Common StockF2,F1Mar 27, 2017S650,000$18.0003D5,170,348D
Common StockF3holding———59,776D
Common StockF4holding———59,776D
Common StockF5holding———59,777D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses